ESE Adrenal Patient Forum 2025 | ESE

The Adrenal Patient Forum webinar is free to attend. Please register by clicking the link below. 10:00 – 10:05 Welcome and introduction Prof. Stefanie Hahner (Germany) Session 1 Chairs: Prof. Stefanie Hahner (Germany) & Jennifer Rayner (UK) 10:05 – 10:20 Understanding ACC and standard treatments Dr. Rossella Libe (France) 10:20 – 10:35 Mitota ne: Effectiveness and managing side effects Dr. Barbara Altieri (Italy) 11:15 – 11:30 Break Session 2 Chairs: Dr. Alessandro Prete (UK) & Jo Grey (UK) 11:30 – 11:45

Read the full article here

Source: www.ese-hormones.org

Categories: Endocrinology, General Medicine News

Tweets with this article

ESEndocrinology_ESE

Our ESE Adrenal Patient Forum 2025 is for patients with adrenocortical carcinoma (ACC). Join our clinical experts for this webinar 'Living with Adrenocortical Carcinoma: Care, Support and What's Ahead'. 📅4 October, 10:00-13:00 CEST Register for free 👉https://t.co/yhxQuAzrDt https://t.co/3rAMXQtGMB

Qualtrics Survey | Qualtrics Experience Management

The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.

Amer. Diabetes Assn. July 22, 2025

36th ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism | ESE

The 36th ESE Postgraduate Training Course in Clinical Endocrinology, Diabetes and Metabolism will take place from Monday 8 September 2025 – Friday 12 September 2025,…

ESEndocrinology_ESE July 22, 2025

Decreased mitochondrial creatine kinase 2 impairs skeletal muscle mitochondrial function independently of insulin in type 2 diabetes

Mitochondrial creatine kinase 2 is decreased in type 2 diabetes, which impairs skeletal muscle mitochondrial function.

EASD July 22, 2025

Socially isolated older adults more likely to develop diabetes

SAN FRANCISCO — Older adults who report being more socially isolated have a higher likelihood for developing diabetes and having an HbA1c of more than…

Endocrine Today July 22, 2025

Tightrope: Obesity Management in Women During Reproductive Years – Endocrine News

As part of the ENDO 2025 session, “Obesity Management Across the Lifespan: Special Considerations,” Lisa Morselli, MD, PhD, talks about the unique challenges in obesity…

Endocrine News July 22, 2025

MAPPS | World Obesity Federation

Management & Advocacy for Providers, Patients and Systems

World Obesity July 22, 2025

Primary adrenal insufficiency caused by pseudo-neonatal adrenoleukodystrophy associated with biallelic ACOX1 mutations

AbstractBackground. Peroxisomal fatty acyl-CoA oxidase 1, encoded by ACOX1, initiates and limits the rate of beta-oxidation of very long-chain fatty acids

Euro J Endocrinology July 22, 2025

From cholesterol to glucose: uncovering how statins induce β-cell dysfunction to promote type 2 diabetes

Statins are the most commonly used cholesterol-lowering medications, with proven efficacy in reducing cardiovascular disease in humans; however, statins are associated with a higher risk…

J. of Endocrinology July 22, 2025

Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study

In sub-Saharan Africa, clinically diagnosed type 1 diabetes is heterogeneous, comprising classic autoimmune type 1 diabetes and a novel, non-autoimmune, insulin-deficient diabetes subtype. There is…

The Lancet Diabetes & Endocrinology July 22, 2025

Non-autoimmune, insulin-deficient diabetes in sub-Saharan Africa

In The Lancet Diabetes & Endocrinology, Jean Claude Katte and colleagues report the results of the cross-sectional Young-Onset Diabetes in sub-Saharan Africa (YODA) study, in…

The Lancet Diabetes & Endocrinology July 22, 2025

Related Articles